Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.
Ashton NJ, Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G, Snellman A, Schöll M, Troakes C, Hye A, Gauthier S, Vanmechelen E, Zetterberg H, Rosa-Neto P, Blennow K. · 2021
Read Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology. by Ashton NJ, Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G, Snellman A, Schöll M, Troakes C, Hye A, Gauthier S, Vanmechelen E, Zetterberg H, Rosa-Neto P, Blennow K. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8043944.txt.
Description
Ashton and co-authors develop a blood test for the earliest stages of Alzheimer's disease. The test measures tau phosphorylated at threonine 231, called p-tau231. The marker was established in spinal fluid, not blood. The team built an ultrasensitive Simoa assay for plasma. They validated it in four independent cohorts totaling 588 people.
Plasma p-tau231 identified Alzheimer's patients with high accuracy, at AUC 0.92–0.94. It separated them from amyloid-negative healthy adults and from other dementias. In a brain-donor cohort, it flagged Alzheimer's pathology years before death. The marker rose earlier than plasma p-tau181 did. It climbed before amyloid scans crossed their standard positive threshold. That early rise could help trials recruit people sooner. Treatment may work best at exactly that stage.
Catalog record
| CREATOR | Ashton NJ, Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G, Snellman A, Schöll M, Troakes C, Hye A, Gauthier S, Vanmechelen E, Zetterberg H, Rosa-Neto P, Blennow K. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |